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Triorganotin(IV) complexes of the 7-amino-2-(methylthio)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic
acid (HL), Me3SnL(H2O), (1), [n-Bu3SnL]2(H2O), (2), Ph3SnL(MeOH), (3), were synthesized by reacting the
amino acid with organotin(IV) hydroxides or oxides in reﬂuxingmethanol. The complexes have been char-
acterized by elemental analysis, 1H, 13C and 119Sn NMR, IR, Raman and 119Sn Mössbauer spectroscopic
techniques. Single crystal X-ray diffraction data were obtained for compounds (2) and (3). Ph3SnL(MeOH)
presents a trigonal bipyramidal structure with the organic groups on the equatorial plane and the axial
positions occupied by a ligand molecule, coordinated to tin through the carboxylate, and a solvent mole-
cule, MeOH. A similar structure is proposed for Me3SnL(H2O) on the basis of analytical and spectroscopic
data. The tributyltin(IV) derivative, [n-Bu3SnL]2(H2O), is characterized by two different tin sites with sim-
ilar tbp geometry featured by butyl groups on the equatorial plane. Sn(1) and Sn(2) atoms are axially
bridged by a ligand molecule binding through the N(4) and the carboxylate group; the two coordination
spheres are saturated by another ligand molecule, binding the metal through the carboxylate group, and a
water molecule, respectively. Antimicrobial tests on compounds 1 and 2 showed in vitro activity against
Gram-positive bacteria.
 2009 Elsevier B.V. All rights reserved.1. Introduction of 7-amino-2-(methylthio)[1,2,4]triazolo[1,5-a]pyrimidine-6-car-[1,2,4]Triazolo[1,5-a]pyrimidine derivatives have been exten-
sively used in the synthesis of metal–ion complexes obtaining a
variety of new compounds with interesting structural features
and relevant biological properties [1,2]. Organotin(IV) complexes
were also recently investigated [3,4]. The coordination studies were
essentially devoted to alkyl- or oxo-substituted triazolopyrimi-
dines, other substituents being ignored. Carboxylate and amino
groups may play an important role in the coordination of organo-
tin(IV) moieties, triorganotin(IV) carboxylates being arousing con-
siderable interest owing to the variety of structures that they may
originate [5] and their biological activity [6–13]. Considering the
important biological role played by triazolopyrimidines, we
decided to investigate the biological and coordinating propertiesAll rights reserved.
oredanacanfora@gmail.com
.unime.it (A. Rotondo), teresa.
ige.it (E.A. Debbia), girasolo@
egna).boxylic acid (HL) complexes with triorganotin(IV) moieties. No lit-
erature data were so far reported on this ligand; its structural
formula is shown in Fig. 1 with the numbering scheme.
2. Experimental
2.1. Materials
The products employed in the present study were purchased
from C. Erba (Milan, Italy), Sigma–Aldrich (Milan, Italy), and Merck
(Milan Italy), and used without further puriﬁcation except metha-
nol, which was distilled over magnesium. The 7-amino-2-(methyl-
thio)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid was a
May-bridge (UK) product commercialized by C. Erba.
2.2. Physical measurements
Elemental analyses (C, H, N, S) were carried out by the micro-
analysis laboratory of the Dipartimento di Scienze Chimiche,
Fig. 1. 7-Amino-2-(methylthio)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylicacid (HL).
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SnO2.
Infrared spectra (nujol and hexachlorobutadiene mulls, CsI win-
dows) were recorded with an FT-IR spectrometer Perkin–Elmer
Spectrum ONE in the 4000–250 cm1 region. Raman Spectra were
acquired by a MicroRaman, Renishaw InVia Spectrometer, using a
50magniﬁcation lens with a 633 nm laser at an intensity of about
1 mW.
The Mössbauer (nuclear c resonance) spectrometer, the related
instrumentation and data reduction procedures were as previously
described [14]. A 10 mCi Ca119SnO3 source (RITVERC GmbH, St.
Petersburg, Russia) was employed. The 1H, 13C and 119Sn NMR
spectra were acquired in CD3OD solutions at 298 K on a Bruker
300 Avance spectrometer at 300.13, 75.47 and 111.92 MHz,
respectively.2.3. Single crystal structural determination by X-ray
Diffraction data for 2 and 3 were measured on a Bruker-Nonius
X8 ApexII diffractometer equipped with a CCD area detector by
using graphite-monochromated Mo Ka radiation (k = 0.71073 Å)
generated from a sealed tube source. Data were collected and re-Table 1
Crystallographic and structure reﬁnement parameters for [n-Bu3SnL]2(H2O) (2) and Ph3Sn
2
Empirical formula C38H68N10O5
Formula weight 1046.58
Temperature (K) 293(2)
Wavelength (Å) 0.71073
Crystal system Orthorhomb
Space group Pbca
Unit cell dimensions
a (Å) 23.2329(4)
b (Å) 16.2894(3)
c (Å) 27.6018(5)
a () 90
b () 90
c () 90
Volume (Å3) 10445.9(3)
Z 8
Density (calculated) (g cm3) 1.331
Absorption coefﬁcient (mm1) 1.082
F(0 0 0) 4304
Crystal size (mm3) 0.3  0.26 
h Range for data collection () 4.13–23.60
Index ranges 26 6 h 6 2
18 6 k 6 1
31 6 l 6 31
Reﬂections collected 186489
Independent reﬂections 7779 [Rint =
Completeness to h 0.99
Absorption correction None
Reﬁnement method Full-matrix
Data/restraints/parameters 7779/229/52
Goodness-of-ﬁt on F2 1.064
Final R indices [I > 2r(I)] R1 = 0.0479,
R indices (all data) R1 = 0.0629,
Largest difference in peak and hole (e Å3) 0.743 and duced by SMART and SAINT software [15] in the Bruker package. The
structure was solved by direct methods [16] and than developed
by least squares reﬁnement on F2 [17]. All non-H atoms were
placed in calculated positions and reﬁned as isotropic with the
‘‘riding-model technique”. Details concerning collection and analy-
sis are reported in Table 1.
The artwork and geometrical parameters are obtained by soft-
ware programs handled by WINGX software package [18]. The reﬁne-
ment is spoiled by the poor quality of the crystals probably
connected with the high thermal motions of the alkyl chains.2.4. Antimicrobial activity
2.4.1. Bacterial strains
Microorganisms used in this study were isolated from clinical
samples. The collection included representative members of the
Enterobacteriaceae family: Escherichia coli (5), Klebsiella pneumoniae
(5), Citrobacter freundii (3), Morganella morganii (3), Enterobacter
cloacae (5), Proteus mirabilis (5), as well as Pseudomonas aeruginosa
(5). Gram-positive strains were Staphylococcus aureus (5), Entero-
coccus faecalis (5) and Streptococcus agalactiae (2).2.4.2. Susceptibility tests
The minimum inhibitory concentrations (MIC) of the com-
pounds studied were determined using the microdilution method
in Mueller-Hinton broth with the addition of Ca2+ and Mg2+. The
microplates were incubated aerobically at 35 C for 18–24 h
according to the recommendations of the Clinical and Laboratory
Standards Institute [19]. E. coli ATCC 25922, P. aeruginosa
ATCC27853, S. aureus ATCC 29213 and E. faecalis ATCC 29212 were
used as controls.L(MeOH) (3).
3
S2Sn2 C26H25N5O3SSn
606.30
293(2)
0.71073
ic Monoclinic
P21/c
10.3585(9)
26.737(2)
9.694(1)
90
100.367(2)
90
2641.0(5)
4
1.525
1.083
4948
0.08 0.3  0.26  0.08
5.52–25.68
6 12 6 h 6 12
8 32 6 k 6 32
11 6 l 6 11
18960
0.0398] 4948 [Rint = 0.0307]
0.99
Sortav
least-squares on F2 Full-matrix least-squares on F2
6 4948/0/326
1.635
wR2 = 0.1407 R1 = 0.0616, wR2 = 0.1852
wR2 = 0.1649 R1 = 0.0681, wR2 = 0.1957
0.494 3.804 and 0.939
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The presence of bioﬁlm was assessed using Congo Red agar
plates, as described by Freeman [20].2.4.4. Evaluation of inhibition of quorum-sensing N-acyl homoserine
lactone signal
Chromobacterium violaceum, a generous gift of Robert McLean
(Texas State University, San Marcos, USA), was used as biosensor.
Quorum sensing inhibition was evaluated either by the overlay
procedure described by McLean [21], or by microdilution tech-
nique employing C. violaceum as test organism.2.5. Synthesis of the complexes
A suspension of 7-amino-2-(methyltio)[1,2,4]triazolo[1,5-
a]pyrimidine-6-carboxylic acid in reﬂuxing methanol was treated
with an equimolar amount of triorganotin(IV) hydroxide or oxide.
A clear solution was obtained in three or four hours; the solvent
was removed in vacuo and the residue was repeatedly recrystal-
lized from n-hexane/methanol mixtures and ﬁnally from methanol
giving crystalline solids.
Me3SnL(H2O) (1) M.p. 259–263 C dec. Anal. Calc. for
C10H17N5O3SSn: C, 29.58; H, 4.22; N, 17.25; S, 7.90; Sn, 29.24.
Found: C, 29.72; H, 4.55; N, 17.30; S, 7.75; Sn, 28.50%. IR (cm1):
1620s masym(OCO), 1361s msym(OCO), 548s masym(SnC3), 511w
msym(SnC3). Raman (cm1): 551w masym(SnC3), 514s msym(SnC3).
119Sn Mössbauer spectrum: d = 1.26, DE = 3.40, C = 0.82 mm s1.
1H NMR; dH: ligand skeleton: 8.82 [s, 1H, H-5], 2.59 [s, 3H, CH3–
S]; Sn–CH3: 0.48 [s, 3H, 2J(119Sn–1H) = 68.6 MHz]. 13C NMR; 170.9
[COOH], 169.3 [C-2], 158.0 [C-6], 157.8 [C-5], 150.6 [C-7], 98.5
[C-3a], 13.8 [CH3–S], 1.6 [CH3–Sn, 1J(119Sn–13C) = 512.9 MHz].
119Sn NMR; d(119Sn): 26.6.
[n-Bu3SnL]2(H2O) (2) M.p. 215–217 C. Anal. Calc. for
C38H68N10O5S2Sn2: C, 43.61; H, 6.55; N, 13.38; S, 6.13; Sn, 22.68.
Found: C, 44.11; H, 6.78; N, 13.30; S, 5.69; Sn, 22.95%. IR (cm1):
1616s masym(OCO), 1365s msym(OCO), 531m masym(SnC2). 119Sn
Mössbauer spectrum: d = 1.41, DE = 3.48, C = 0.76 mm s1. 1H
NMR; dH: ligand skeleton: 8.84 [s, 1H, H-5], 2.70 [s, 3H, CH3–S];
Sn–nBu3: 1.73–0.92 [m, 9H]. 13C NMR; 170.8 [COOH], 169.3 [C-
2], 158.0 [C-6], 157.7 [C-5], 150.7 [C-7], 98.4 [C-3a], 29.2 [b-CH2,
Bu3–Sn], 28.1 [c-CH2, Bu3–Sn], 18.7 [a-CH2, Bu3–Sn,
1J(119Sn–13C) = 453.5 MHz], 14.1 [CH3, Bu3–Sn], 13.8 [CH3–S].
119Sn NMR; d(119Sn): 19.1.
Ph3SnL(MeOH) (3) M.p. 197–199 C. Anal. Calc. for
C26H25N5O3SSn: C, 51.51; H, 4.16; N, 11.55; S, 5.29; Sn, 19.58.
Found: C, 51.75; H, 3.99; N, 11.63; S, 5.21; Sn, 19.50%. IR(cm1):
1605s masym(OCO), 1365s msym(OCO), 272m masym(SnC2); 574m
m(Sn–O). 119Sn Mössbauer spectrum: d = 1.25, DE = 3.12,
C = 0.79 mm s1. 1H NMR; dH: ligand skeleton: 8.80 [s, 1H, H-5],
2.55 [s, 3H, CH3–S], Sn–Ph3: 7.80–7.40 [m]. The very low solubility
of the triphenyltin derivative did not allow to record 13C and 119Sn
NMR spectra for this compound.3. Results and discussion
3.1. Spectroscopic data
In the infrared spectra of the complexes 1–3 the m(CO) strong
band of the ligand (1701 cm1) is replaced by a couple of intense
absorptions in the 1605–1620 and 1361–1365 cm1 regions, which
may be attributed to the asymmetric and symmetric m(CO2)
stretching mode, respectively. The high values of Dm (masym(O–
C@O)msym(O–C@O) > 230 cm1), strongly suggest an unidentate
coordination by the carboxylate group [22].The arrangement of the carbon atoms in the Sn(Alk)3 group can
be easily deduced from the tin–carbon stretching modes which oc-
cur in the 550–500 cm1 region of the infrared and Raman spectra
[23]. The infrared spectrum of Me3SnL(H2O) shows a strong
absorption at 548 cm1 and a weak absorption at 511 cm1 which
can be assigned to masym(Sn–C3) and msym(Sn–C3), respectively. The
corresponding absorptions in the Raman spectrum are at 551 and
514 cm1 with reversed intensity. The large difference in the inten-
sity of asymmetric and symmetric Sn–C3 absorptions is indicative
of an essentially planar arrangement of the SnC3 group [23].
The 119Sn Mössbauer spectrum is characterized by a quadruple
splitting value of 3.40 mm s1, fully consistent with a trigonal
bipyramidal structure with organic groups in the equatorial plane
and electronegative ligands in axial positions [24], tin being 5-
coordinate.
The spectral analogies suggest the same ligand arrangement for
all triorganotin(IV) complexes in the solid state.
The NMR spectral data point out that the nearly planar arrange-
ment of the organic groups in trialkyltin derivatives is retained in
methanol solution. The C–Sn–C bond angle may be evaluated from
the coupling constants |2J(119Sn–1H)| and |1J(119Sn–13C)|. The rela-
tionships derived by Lockhart and Manders for methyltin(IV)
derivatives give C–Sn–C bond angles of 119 (|2J|, Ref. [25]) and
121 (|1J|, Ref. [26]), for compound (1) while the relationship pro-
posed by Holecˇek and Licˇka for n-butyltin(IV) derivatives give a
C–Sn–C bond angle of 120 (|1J|, Ref. [27]) for compound (2). Be-
sides, the values of d(119Sn) are compatible with ﬁve-coordinate
trialkyltin(IV) compounds [28].
In the solid state, tin expands his coordination number through
bridge coordination of the ligand or the coordination of a solvent
molecule. The ligand would in principle bind tin atom through
the amino group, an endocyclic nitrogen atom or the thioether sul-
phur atom. The latter possibility is excluded by the absence of
stretching absorptions which may be assigned to Sn–S bonds
[29]. Concerning the amino group, the infrared spectra of the com-
plexes do not show meaningful changes in the N–H stretching fre-
quencies, as expected on the basis of the low basicity of the amine
nitrogen, due to the electron-drawing effect of the carboxylic
group and the endocyclic nitrogen N(4). N(4) and N(3) are then
the most probable coordination sites, according to the structures
reported for metal derivatives of triazolopyrimidines [1].
The presence of a N(3)–Sn or N(4)–Sn bond is hard to diagnose
as the m(Sn–N) stretching frequencies have been reported on an ex-
tremely wide range, so, considering the high number of the ligand
absorptions, it is not possible to make unambiguous assignments.
The N(3)–metal bond causes a shift of the m(tp) and m(py) frequen-
cies assigned to the vibrations of triazolopyrimidine and pyrimi-
dine ring, respectively. Such shifts, however, have been observed
only in the spectra of the triazolopyrimidine (tp) and its derivatives
containing alkyl or aryl groups in 5 and 7 positions, which coordi-
nate the metal centre only through N(3) [4]. On the other hand, the
coordination of metallic ions through N(3) do not inﬂuences 1H
and 13C NMR spectra nearly at all, as observed in stable metal com-
plexes of 5,7-dimethyltriazolopyrimidine [30]. Also the 15N NMR
spectra are very little inﬂuenced by coordination, shifts of about
0.5 ppm having been observed in spectra of Zn(II) complexes of
tp, dmtp, dptp and dbtp, in contrast with the 10–60 ppm shifts ob-
served in other complexes with N-donor molecules, such as imid-
azole or 1-methylimidazole [31].
The spectroscopic data suggest a tbp structure for triorgano-
tin(IV) derivatives where C atoms of the organotin moiety lie on
the equatorial plane while the axial positions are occupied by an
unidentate carboxylate group and an endocyclic nitrogen atom.
X-ray crystallographic data are consistent with the spectroscopic
evidences, but they show slight differences in the molecular struc-
tures of the tri-n-butyltin(IV) 2 and triphenyltin(IV) 3 complexes
Table 2
Selected bond distances (Å) and angles () for 2 and 3.
Structure 2 Structure 3
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6-carboxylic acid, pointing out that water and methanol molecules
coordinate tin.Sn1–C16 2.115(6) Sn1–C16 2.123(5)
Sn1–C20 2.153(6) Sn1–C22 2.146(5)
Sn1–C24 2.118(6) Sn1–C28 2.127(5)
Sn1–O15 2.157(3) Sn1–O15 2.142(4)
Sn1–N32 2.620(3) Sn1–O34 2.507(4)
Sn2–C43 2.131(5)
Sn2–C47 2.131(5)
Sn2–C51 2.130(4)
Sn2–O42 2.133(3)
Sn2–O55 2.573(4)
C20–Sn1–C16 112.8(3) C16–Sn1–C22 111.5(2)
C24–Sn1–C20 126.4(2) C16–Sn1–C28 125.1(2)
C24–Sn1–C16 115.5(7) C22–Sn1–C28 111.5(2)
O15–Sn1–C16 89.3(2) O15–Sn1–C16 96.8(2)
O15–Sn1–C20 96.8(2) O15–Sn1–C22 90.8(2)
O15–Sn1–C24 98.7(2) O15–Sn1–C28 100.9(2)
O15–Sn1–N32 176.0(1) O15–Sn1–O34 176.7(1)
C24–Sn1–N32 83.6(2) C16–Sn1–O34 83.3(2)
C20–Sn1–N32 84.4(2) C22–Sn1–O34 86.2(2)
C16–Sn1–N32 86.7(2) C28–Sn1–O34 81.6(2)
C43–Sn2–C47 121.4(2)
C43–Sn2–C51 117.8(2)
C47–Sn2–C51 118.6(2)
O55–Sn2–C43 86.5(2)
O42–Sn2–C43 97.8(2)
O42–Sn2–C47 96.8(2)
O42–Sn2–C51 90.4(2)
O55–Sn2–C47 82.7(2)
O55–Sn2–C51 85.7(1)
O55–Sn2–O42 175.2(1)3.2. X-ray crystallography
Colourless crystals, suitable for the X-ray analysis, where ob-
tained by slow evaporation from methanol solutions. X-ray reﬂec-
tions analysis shows that 2 crystallizes in the orthorhombic space
group Pbca. The asymmetric unit is occupied by a neutral bimetal-
lic complex with two non-equivalent Sn atoms. Beyond the ex-
pected alkyl groups, two ligands L and a water molecule
populate the metals’ coordination spheres (Fig. 2).
Both metallic centres keep the tbp coordinating geometry often
shown by trialkyl-tin with oxygenated and nitrogenated axial li-
gands (Table 2) [32]. The two L ligands result different since one
coordinates Sn1 just by the O15 of the carboxylate group, whereas
the other one bridges the two metals binding Sn1 through the N32
of the purine moiety and Sn2 with O42 on the carboxylate group.
The position of the axial binding atoms is remarkably asymmet-
rical because of the negative electron density over the carboxylate
O atoms which thus approach the metal more than the opposing
axial atom (Table 2 and similar structures [33]). The long Sn1–
N32 distance (2.620(3) ÅA
0
) is not really unexpected since other sim-
ilar systems show this same feature [33b]. The whole three-dimen-
sional structure is supported by hydrogen interactions occurring
between the several H-donors and acceptors (Fig. 3, Table 3). It
has to be mentioned also a staggered graphitic interaction between
the aromatic cores of two L units belonging to molecules related by
the symmetry operation x, y, z + 1 (distance between mean
planes 3.352(3) Å), whose edges (N3–C4–N5) are closer than the
sum of atoms van der Waals radii.Fig. 2. ORTEP molecular representation for 2with atom labelling scheme. Ellipsoids
of 30% probability are shown for anisotropic atoms, while n-butyl groups, thermally
disordered, and hydrogen atoms are depicted as arbitrary radium spheres.
Fig. 3. The XP(Bruker) packing diagram of a unit cell of 2. The most relevant
hydrogen interactions are evidenced as dashed lines.
Table 3
Hydrogen interactions with related structural parameters for 2 (Å and ).
D–H  A (D–H) (Å) (H  A) (Å) (D  A) (Å) (D–H  A) ()
N12–H12A  O41#1 0.86 2.19 2.920(7) 142.2
N12–H12B  O14 0.86 2.06 2.674(7) 127.3
N39–H39A  N5#2 0.86 2.14 2.924(6) 152.1
N39–H39B  O41 0.86 2.11 2.714(6) 126.4
N39–H39B  N1#3 0.86 2.54 3.183(6) 132.6
O55–H55B  N3#4 0.94 2.11 2.781(7) 126.8
Symmetry transformations used to generate equivalent atoms: #1 x + 1/2, y,
z + ½; #2 x + 1/2, y, z + ½; #3 x + 1/2, y, z ½; #4 x, y + 1/2, z + 1/2.
Table 4
Hydrogen interactions with related structural parameters for 3 (Å and ).
D–H  A (D–H) (Å) (H  A) (Å) (D  A) (Å) (D–H  A) ()
O34–H34  N3#1 0.96 1.95 2.842(6) 153.7
N12–H12B  O14 0.86 2.05 2.665(6) 127.8
Symmetry transformations used to generate equivalent atoms: #1 x  1, y, z  1.
Fig. 5. 1Dmolecular array of 3 (in balls and sticks) along the [1 0 1] crystallographic
direction. Intermolecular hydrogen bonds are represented as dashed lines. Hydro-
gens not involved in the intermolecular interaction are omitted for clarity.
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shows a tbp monometallic complex whose axial Sn1 binding atoms
are the carboxylate O15 coming from an L unit, and the O34
belonging to a coordinated methanol molecule (Fig. 4). Beyond
the peripheral molecular differences, the Sn coordination geome-
tries for structures 2 and 3 present similar features as shown in Ta-
ble 2. The main intermolecular hydrogen interaction for the solid
state of 3 generates a one-dimensional array of molecules along
the diagonal of the a and c crystallographic axes (Table 4 and
Fig. 5). Other weaker dipolar interactions support the molecular
packing along the other directions.
3.3. Antimicrobial activity
Owing to the low solubility of the triphenyltin compound and of
the ligand itself, antimicrobial activity tests were effected only on
compounds 1 and 2. The great majority of Gram-negative tested
organisms (31) resulted poorly susceptible to compound 2, the
MIC values ranging from 1000 to 2000 mg/L, while Gram-positive
isolates (12) were all inhibited at a dose 64 mg/L of the compound
with the exception of the two strains of S. agalactiae which exhib-
ited MIC values of 0.5 and 2 mg/L (data not shown). The in vitro
activity of 1 was similar to that of 2, against many members of
the Enterobacteriaceae family (MICP 1000 mg/L). Some differences
were found in the MIC values registered with P. aeruginosa
(MIC = 250 mg/L) and in a single isolate of E. coli, E. cloacae and P.
mirabilis (MIC = 500 mg/L). Gram-positive bacteria resulted inhib-
ited at concentrationsP1000 mg/L with the exception of S. agalac-
tiae (MIC = 32 mg/L).
As reported in Table 5 both compounds 1 and 2 at a sub-MIC
concentration (500 mg/L) inhibited bioﬁlm production in all the
Gram-negative bacteria studied, swarming in P. mirabilis, and pig-
ment production in P. aeruginosa. Similar results were obtained
employing the comparative agent azithromycin. With respect to
Gram-positive isolates, bioﬁlm-inhibition was not found exposing
the bacteria to sub-inhibitory concentration of compound 2, while
both azithromycin and 1 affected this trait in all the strains tested.
When C. violaceum was used as biosensor for quorum-sensingFig. 4. ORTEP representation of 3 with atom labelling scheme. Thermal ellipsoids are drawn at the 30% probability level.
Table 5
Effects of compounds 1 and 2 (0.5 MIC) and azithromycin, as comparative agent, on pathogenicity traits of representative bioﬁlm-producing microorganisms.
Compound 1 Compound 2 Azithromycin
Pathogenicity trait Pathogenicity trait Pathogenicity trait
Strains (no. of strains tested) Bioﬁlm Pigment Swarming Bioﬁlm Pigment Swarming Bioﬁlm Pigment Swarming
E. coli (5) + na na + na na + na na
K. pneumoniae (3) + na na + na na + na na
E. cloacae (2) + na na + na na + na na
C. freundii (1) + na na + na na + na na
M. morganii (1) + na na + na na + na na
P. mirabilis (3) + na + + na + + na +
P. aeruginosa (5) + + na + + na nt + na
S. aureus (3) + na na  na na + na na
E. faecalis (3) + na na  na na + na na
E. coli ATCC 25922 na na na np na na na na na
P. aeruginosa ATCC 27853 nt + na np + na nt + na
S. aureus ATCC 29213 + na na  na na + na na
E. faecalis ATCC 29212 + na na  na na + na na
C. violaceum ATCC 12477 nt + na nt + na nt + na
+ or : inhibition or not inhibition of the trait tested on all strains, respectively, na: not applicable, nt: not tested, np: non-producing.
G. Ruisi et al. / Journal of Organometallic Chemistry 695 (2010) 546–551 551signals, it demonstrated susceptibility to compound 2 (MIC = 4 mg/
L, the same value registered with azithromycin) and 1 (MIC =
32 mg/L). In the tests for the evaluation of pigment production all
the compounds demonstrated to affect violacein synthesis under
the same experimental conditions (0.5 MIC).
The present ﬁndings indicate that the in vitro activity of
these compounds against both Gram-positive and Gram-negative
bacteria varied in an unpredictable way. This is probably due to
the different ability of the compounds to cross the cell wall of
Gram-positives and Gram-negative bacteria. An interesting point
is the inhibition of the quorum-sensing signal in all the species.
Although it was noted in some circumstances at high concentra-
tion (500 mg/L), it demonstrated a speciﬁc inﬂuence of this phe-
nomenon in all the strains studied. Since quorum-sensing in
Gram-positive and Gram-negative isolates is mediated by differ-
ent compounds [34], both compounds 1 and 2 appeared to
affect acyl-homoserine lactone family compounds while 1 re-
sulted to possess activity also on Gram-positive mediators as
seen in bioﬁlm production of Gram-positive strains. Although
this last point requires further studies, these compounds appear
good candidates to circumvent antibiotic resistance problem
interfering with virulence and pathogenicity traits in bacteria,
that is considered the new strategy for the therapy of infectious
diseases.
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Appendix A. Supplementary material
CCDC 735808 and 735809 contain the supplementary crystallo-
graphic data for 2 and 3. These data can be obtained free of charge
fromThe Cambridge Crystallographic Data Centre viawww.ccdc.ca-
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article can be found, in the online version, at doi:10.1016/
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